Salata to Chair Infectious Diseases Working Group for Ohio Clinical Trials Collaborative

Working Group Will Advance New Treatments for Current and Emerging Infectious Diseases

2014 BIO International Convention

CLEVELAND--()--The Ohio Clinical Trials Collaborative (OCTC) announces the appointment of Robert A. Salata, MD, as Chair of its Infectious Diseases Working Group. An internationally renowned infectious disease expert, Salata is Chief of Infectious Disease and HIV Medicine Division at University Hospitals Case Medical Center and Professor of Medicine at Case Western Reserve University School of Medicine.

“Infectious diseases represent the greatest proportion of new diseases discovered over the past 35 years, and emerging and re-emerging infections continue to represent a global threat to human health,” said Salata. “I am pleased to lead this statewide initiative related to infectious diseases clinical trials for the OCTC to help industry develop new treatment and prevention strategies.”

The OCTC provides centralized access to Ohio’s premier medical centers for clinical trial development. The pharmaceutical industry faces a challenging and expensive process for conduct of clinical trials. The OCTC streamlines the contracting, budgeting, approval of human subject use and patient recruitment/enrollment processes so that medical discoveries can move to market faster.

“The OCTC seeks to establish Ohio as one of the most efficient and effective states in which to develop new medicines and treatment strategies. Infectious diseases are an area of unmet need where we look to support industry sponsored clinical trials,” said James Chmiel, MD, MPH, Chief Executive and Director of the OCTC.

About the Ohio Clinical Trials Collaborative
The OCTC is an initiative under Governor John Kasich’s vision of a premier research medical corridor in Ohio that is co-founded by the Clinical and Translational Science Collaborative at Case Western Reserve University, the Center for Clinical and Translational Science at The Ohio State University and the Center for Clinical and Translational Science and Training at the University of Cincinnati. With offices at Case Western Reserve University’s School of Medicine, the OCTC seeks to establish Ohio as one of the most efficient and effective states in which to test new medications and treatment strategies. The OCTC offers economies of scale and unique capacity, leveraging expertise from across the state of Ohio to conduct clinical trials on behalf of industry sponsors. For more information, please go to www.ohioclintrials.org.

About University Hospitals Case Medical Center
UH, the second largest employer in Northeast Ohio, serves the needs of patients through an integrated network of hospitals, outpatient centers and primary care physicians in 16 counties. At the core of our health system is University Hospitals Case Medical Center, one of only 18 hospitals in the country to have been named to U.S. News & World Report’s most exclusive rankings list: the Best Hospitals 2013-14 Honor Roll. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation and the world, including cancer, pediatrics, women's health, orthopaedics and spine, radiology and radiation oncology, neurosurgery and neuroscience, cardiology and cardiovascular surgery, organ transplantation and human genetics. Its main campus includes the internationally celebrated UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. UH Case Medical Center is the 2012 recipient of the American Hospital Association – McKesson Quest for Quality Prize for its leadership and innovation in quality improvement and safety. For more information, go to www.uhhospitals.org.

Contacts

Business Contact:
Ohio Clinical Trials Collaborative
John Peterson, PhD, Global Business Development Director, 216-368-0180
john.r.peterson@case.edu
or
Media Contact:
Jessica Studeny, 216-368-4692
jes91@case.edu

Sharing

Contacts

Business Contact:
Ohio Clinical Trials Collaborative
John Peterson, PhD, Global Business Development Director, 216-368-0180
john.r.peterson@case.edu
or
Media Contact:
Jessica Studeny, 216-368-4692
jes91@case.edu